Definium Therapeutics Inc (DFTX)
$36.33 -4.29% Close Oct 30, 2026 Live
Definium Therapeutics stock today
Definium Therapeutics closed at $36.33 on October 30, 2026, down 4.29% on the day. Over the past year it returned +171.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.96 billion.
$20.00$40.00
NovJan 2026MarMayJulSep
| Period | DFTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.5% | -0.9% |
| 3 months | -18.3% | +2.1% |
| Year to date | +171.3% | +11.7% |
| 1 year | +171.3% | +12.4% |
| 3 years | +1,308% | +88.5% |
Key statistics
- Market value
- $3.96B
- 52-week range
- $10.68 to $48.45
- Next report
- Nov 9, 2026
About Definium Therapeutics
Definium Therapeutics develops pharmaceutical treatments for oncology and other disease areas.
Sector: Health Care
More on Definium Therapeutics
- Returns: what $1,000 became$1,000 three years ago is $14,081 today
No forecast, no recommendation. This page describes Definium Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.